Below is a list of Nonalcoholic Fatty Liver Disease clinical trials from the clinical trials database at Mayo Clinic.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.
Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
The incidence of Non alcoholic fatty liver disease (NAFLD) continues to increase, and prevalence estimates for NAFLD range from 17-33%, making it is the most common cause of chronic liver disease in North America.
Read more
Find Mayo Clinic on